The WHO has declared the end of pandemic phase of COVID‐19: Way to come back in the normal life

Author:

Sarker Rapty1,Roknuzzaman A. S. M.1,Nazmunnahar 2,Shahriar Mohammad1,Hossain Md. Jamal3ORCID,Islam Md. Rabiul14ORCID

Affiliation:

1. Department of Pharmacy University of Asia Pacific Dhaka Bangladesh

2. Department of Sociology, Eden Women's College National University Bangladesh Gazipur Bangladesh

3. Department of Pharmacy State University of Bangladesh Dhaka Bangladesh

4. School of Pharmacy BRAC University Dhaka Bangladesh

Abstract

AbstractThe coronavirus disease 2019 (COVID‐19) pandemic has resulted in significant global mortality and morbidity affecting millions of lives. As healthcare authorities worldwide are still paying substantial attention to COVID‐19, other diseases continue to cause more deaths than COVID‐19. The decreasing number of COVID‐19 cases and deaths indicates that the pandemic is close to the end. For effective pandemic management, healthcare facilities worldwide have established COVID‐19 units and testing facilities, instituting infection prevention and control measures, and employing telehealth services. Healthcare professionals have identified some promising treatments for COVID‐19; also, mass vaccinations have improved patient outcomes. Instead of COVID‐19 as a pandemic, it is time to pay more attention to other diseases to lessen their impact on public health. Therefore, the World Health Organization (WHO) has declared the end of the pandemic phase of COVID‐19 considering the current COVID‐19 situation and our preparedness, past pandemic experience, and long pandemic impact on social and economic life on May 5, 2023. In this article, we briefly discussed the present challenges due to COVID‐19, necessary precautions, and future directions to return to life as before COVID‐19.

Publisher

Wiley

Subject

General Medicine

Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Implications of Dysnatremia and Endocrine Disturbances in COVID-19 Patients;International Journal of Molecular Sciences;2024-09-12

2. Annual Pharmaceutical Sales Estimates Using Patents;2024 Portland International Conference on Management of Engineering and Technology (PICMET);2024-08-04

3. Pituitary surgery and COVID;Pituitary;2024-07-05

4. Coronavirus Disease 2019 Knowledge, Its Vaccine Uptake Intentions, and the Influence of Personality Traits among Undergraduate Pharmacy Students in a University Setting: Findings and Implications;Annals of African Medicine;2024-07

5. COVID-19 surge during summer 2024: the phantom menace?;Clinical Microbiology and Infection;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3